Can $200 Really Buy You An Accurate Look At Your Genetic Risk For Diseases?
California-based 23andMe, a genetic testing company, recently won FDA approval to sell its product, which tells users if they are susceptible to certain diseases. Stat offers a look at what consumers need to know about it before considering using it.
Before You Send Your Spit To 23andMe, What You Need To Know
The genetic testing company 23andMe received approval this week from regulators to sell genetic reports on an individual’s risk for 10 diseases, most prominently Alzheimer’s and Parkinson’s. Before you send in your saliva sample and $199, here’s what you should know. (Begley, 4/7)
San Diego Union-Tribune:
Concern Raised About 23andMe's New Genetic Tests For Disease
The FDA has given 23andMe the right to sell members of the public genetic tests that estimate a person’s risk for 10 health conditions, including Parkinson’s and late-onset Alzheimer’s disease. The decision drew concern from Laura Rivard, a genetics professor at the University of San Diego. (Robbins, 4/7)